Canopy Rivers (CNPOF)

$0.85 0.01 (1.43%)

15:44 EST CNPOF Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 74,263

Day's Range 0.84 - 0.89

52-Week Range 0.37 - 1.30

Dividend & Yield N/A (N/A)

CNPOF Stock Predictions, Articles, and Canopy Rivers News

From InvestorPlace
From the Web

Canopy Growth Stock And Its Sister Company Are Both Attractive

By Will Ashworth, InvestorPlace Contributor Dec 19, 2018

If you’re thinking about buying Canopy Growth stock, before you buy CGC stock, you could consider investment company Canopy Rivers.

The Week In Cannabis: Stocks Down Amid Earnings Season, Argentina Regulates Medical Marijuana

From Benzinga Nov 14, 2020

Cannabis stocks were back in the red this week, retreating from post-election highs amid an earnings-heavy period. Over the five trading ...

Earnings Update: Aurora, Canopy Growth, Canopy Rivers And Zynerba Each Post Results

From Benzinga Nov 9, 2020

Aurora Posts Q1 EBITDA Loss, Expects Positive EBITDA In Q2 Aurora Cannabis Inc. (NYSE:

Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results

From BusinessInsider Nov 3, 2020

TORONTO, Nov. 2, 2020 /PRNewswire/ - Canopy Rivers Inc. ('Canopy Rivers' or the 'Company') (TSX: RIV) (OTC: CNPOF) will report its second quarter ...

Canopy Rivers portfolio companies expand U.S. offerings (OTCMKTS:CNPOF)

From Seeking Alpha Oct 9, 2020

Canopy Rivers (OTCPK:CNPOF) provides an update on the progress three of its portfolio companies in U.S. TerrAscend commenced sales from its newly expanded State Flower cultivation facility in San Francisco.

This Week In Cannabis: Mixed Stock Performers, Big Financings, Platform Launches, And More

From Benzinga Sep 19, 2020

This was a mixed week for cannabis stocks, with some ETFs in the green and others in the red. Over the five trading days of the week: The ETFMG Alternative Harvest ETF (NYSE: MJ...

Canopy Rivers receives statement of claim for joint venture dispute

From Seeking Alpha Sep 14, 2020

Canopy Rivers (OTCPK:CNPOF) says it received a statement of claim filed by 2615975 Ontario concerning certain disputes with the Company's joint venture partner PharmHouse.The claim makes a number of allegations against the Company and TerrAscend and TerrAscend Canada relating to bad faith, fraud, civil conspiracy, breach of the duty of honesty and good faith in contractual relations and breach of fiduciary duty, and claims relating to PharmHouse's offtake agreements with Canopy Growth and TerrAscend.Canopy Rivers considers the claim to be completely without merit, and intends to vigorously defend its position at the appropriate time and in the appropriate forum.Canopy Rivers has formed a special committee of independent directors to oversee and provide guidance relating to the Company's investment in PharmHouse as well as to consider strategic alternatives for the Company regarding its investment in PharmHouse and directing the Company's defence against, the Claim.